|
| Press Releases |
|
 |
|
| Friday, March 7, 2025 |
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its annual results for the year ended December 31, 2024 (the 'Year'), reporting record-high revenue and healthy net profit despite the challenging business landscape. more info >> |
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至截至2024年12月31日止年度（「年度」）的全年業績。 more info >> |
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（“业聚医疗”或“集团”；股份代号：6929）今天宣布截至截至2024年12月31日止年度（“年度”）的全年业绩。 more info >> |
|
| Friday, August 16, 2024 |
|
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2024 (the 'Reporting Period), with revenue and profit for the period attributable to owners of the Company maintained at US$78.9 million and US$18.8 million respectively despite various market challenges. more info >> |
|
|
业聚医疗2024年上半年纯利达1,880万美元 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」；股份代号：6929）今天宣布截至2024年6月30日止六个月(「报告期」)的中期业绩。 more info >> |
|
|
業聚醫療2024年上半年純利達1,880萬美元 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2024年6月30日止六個月(「報告期」)的中期業績。 more info >> |
|
| Wednesday, April 24, 2024 |
|
|
业聚医疗合资企业在中国内地启动TricValve临床试验 |
| more info >> |
|
|
業聚醫療合資企業在中國內地啟動TricValve臨床試驗 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天公佈，其合資企業業聚培福有限公司（「業聚培福」）旗下用作治療血流動力學相關的三尖瓣功能不全和腔靜脈回流的產品——TricValve經導管雙腔靜脈瓣膜系統（「TricValve」），已於2024年4月22日在中國內地展開臨床試驗。 more info >> |
|
|
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China |
| OrbusNeich Medical Group Holdings Limited announced today that the Group's joint venture OrbusNeich P+F Company Limited ("ON P&F") has commenced the clinical trial for the TricValve Transcatheter Bicaval Valve System ("TricValve"), to treat patients with hemodynamically relevant tricuspid insufficiency and caval reflux, on April 22, 2024 across Mainland China. more info >> |
|
| Thursday, March 7, 2024 |
|
|
業聚醫療收入純利雙雙創新高 分別約1.54億美元及4,510萬美元 建議派發末期股息每股10港仙 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929），今天公佈截至2023年12月31日止年度的全年業績。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通と米FICO、金融業界のデジタル化による業務効率化や収益最大化を支援するためパートナーシップを締結
Mar 19, 2025 10:10: JST
|
|
|
Fujitsu and FICO partner to accelerate digital transformation in financial services
Mar 19, 2025 10:30 JST
|
|
|
Singapore's Salary Expectations Evolve as 53% Professionals Seek Better Compensation, foundit Survey Reveals
Mar 19, 2025 08:55 HKT/SGT
|
|
|
Salary Divide: While 47% of professionals in Philippines Report Above-Average Compensation, 42% See Room for Growth, foundit Survey Reveals
Mar 19, 2025 08:50 HKT/SGT
|
|
|
China BlueChem Reports 2024 Revenue of RMB11.946 Billion
Mar 18, 2025 23:24 HKT/SGT
|
|
|
HER Courage Leaders Summit 2025: Expanding Women's Leadership Across ASEAN
Mar 18, 2025 23:15 HKT/SGT
|
|
|
中海石油化學2024年實現收入人民幣119.46億元
Mar 18, 2025 22:57 HKT/SGT
|
|
|
中海石油化学2024年实现收入人民币119.46亿元
Mar 18, 2025 22:51 HKT/SGT
|
|
|
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce
Mar 18, 2025 23:36 JST
|
|
|
陳力博士當選上海市工商業領軍人物
Mar 18, 2025 22:28 HKT/SGT
|
|
|
陈力博士当选上海市工商业领军人物
Mar 18, 2025 22:16 HKT/SGT
|
|
|
數字生態矩陣趨完善：通通AI社交集團公告併購兩企
Mar 18, 2025 22:08 HKT/SGT
|
|
|
数字生态矩阵趋完善：通通AI社交集团公告并购两企
Mar 18, 2025 22:02 HKT/SGT
|
|
|
USPA Global and Global Polo Entertainment Extend Historic ESPN Relationship
Mar 18, 2025 20:00 HKT/SGT
|
|
|
氧化鋁東南亞龍頭南山鋁業國際開啟香港招股
Mar 18, 2025 18:52 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
